Contraception Progestin Type and Female Pattern Hair Loss

    August 2021 in “ Journal of The American Academy of Dermatology ”
    Kelly E. Flanagan, James T. Pathoulas, Chloe J. Walker, Laura J. Burns, Isa Pupo Wiss, Maryanne M. Senna
    TLDR Newer contraceptives with less androgenic progestins may reduce female hair loss.
    The document discussed the relationship between different types of progestins in hormonal contraceptives and female pattern hair loss (FPHL). It highlighted that androgens are believed to play a role in FPHL by shortening the follicular growth phase and causing miniaturization of hair follicles. The study noted that first-generation progestins have the highest androgen activity, while newer generations have progressively less androgenic activity, with some newer progestins being antiandrogenic. This suggests that the type of progestin in contraceptives could influence the severity of FPHL.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 7 results

    Similar Research

    5 / 1000+ results
      Medical Treatment of Alopecia

      research Medical Treatment of Alopecia

      October 2018 in “InTech eBooks”
      The most effective treatments for hair loss are minoxidil, finasteride, PRP, and hair transplants, with steroids and immunosuppressants for autoimmune types.

      research Hormonal Effects on Hair Follicles

      102 citations, July 2020 in “International journal of molecular sciences”
      Hormones like testosterone and estrogen significantly affect hair growth and structure.
      Alopecia: Managing the Basics

      research Alopecia: Managing the Basics

      July 2015 in “Cambridge University Press eBooks”
      The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

      research Female Pattern Hair Loss: An Update

      12 citations, January 2020 in “Indian Dermatology Online Journal”
      Female pattern hair loss has multiple causes and treatments, with new therapies showing promise.